aluates Reports

$ 0.0

Automative

Immune Globulin Subcutaneous - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-35C272

Global Immune Globulin Subcutaneous Market Professional Survey Report 2019

BUY CHAPTERS

Immune Globulin Subcutaneous - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-35C272

Report

September 2024

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CSL Limited

Takeda

Immune Globulin Subcutaneous - Market Size

The global market for Immune Globulin Subcutaneous was estimated to be worth US$ 1864 million in 2023 and is forecast to a readjusted size of US$ 2786.8 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030

Immune Globulin Subcutaneous - Market

Immune globulin subcutaneous (for injection under the skin) is used to treat primary immunodeficiency

North American market for Immune Globulin Subcutaneous was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Immune Globulin Subcutaneous was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Immune Globulin Subcutaneous was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Immune Globulin Subcutaneous include Takeda and CSL etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Immune Globulin Subcutaneous, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Immune Globulin Subcutaneous by region & country, by Type, and by Application.

The Immune Globulin Subcutaneous market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Globulin Subcutaneous.

Market Segmentation

Scope of Immune Globulin Subcutaneous - Market Report

Report Metric	Details
Report Name	Immune Globulin Subcutaneous - Market
Forecasted market size in 2030	US$ 2786.8 million
CAGR	5.8%
Forecasted years	2024 - 2030
Segment by Type:	2g 4g 10g Other
Segment by Application	Immunodeficiency Autoimmune Disease Acute Infection
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, CSL
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Immune Globulin Subcutaneous manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Immune Globulin Subcutaneous in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Immune Globulin Subcutaneous in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Immune Globulin Subcutaneous - Market size in 2030?

Ans: The Immune Globulin Subcutaneous - Market size in 2030 will be US$ 2786.8 million.

Who are the main players in the Immune Globulin Subcutaneous - Market report?

Ans: The main players in the Immune Globulin Subcutaneous - Market are Takeda, CSL

What are the Application segmentation covered in the Immune Globulin Subcutaneous - Market report?

Ans: The Applications covered in the Immune Globulin Subcutaneous - Market report are Immunodeficiency, Autoimmune Disease, Acute Infection

What are the Type segmentation covered in the Immune Globulin Subcutaneous - Market report?

Ans: The Types covered in the Immune Globulin Subcutaneous - Market report are 2g, 4g, 10g, Other

Recommended Reports

Immune Globulin Markets

Subcutaneous Therapies

Immune Therapy & Diagnostics

1 Market Overview

1.1 Immune Globulin Subcutaneous Product Introduction

1.2 Global Immune Globulin Subcutaneous Market Size Forecast

1.2.1 Global Immune Globulin Subcutaneous Sales Value (2019-2030)

1.2.2 Global Immune Globulin Subcutaneous Sales Volume (2019-2030)

1.2.3 Global Immune Globulin Subcutaneous Sales Price (2019-2030)

1.3 Immune Globulin Subcutaneous Market Trends & Drivers

1.3.1 Immune Globulin Subcutaneous Industry Trends

1.3.2 Immune Globulin Subcutaneous Market Drivers & Opportunity

1.3.3 Immune Globulin Subcutaneous Market Challenges

1.3.4 Immune Globulin Subcutaneous Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Immune Globulin Subcutaneous Players Revenue Ranking (2023)

2.2 Global Immune Globulin Subcutaneous Revenue by Company (2019-2024)

2.3 Global Immune Globulin Subcutaneous Players Sales Volume Ranking (2023)

2.4 Global Immune Globulin Subcutaneous Sales Volume by Company Players (2019-2024)

2.5 Global Immune Globulin Subcutaneous Average Price by Company (2019-2024)

2.6 Key Manufacturers Immune Globulin Subcutaneous Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Immune Globulin Subcutaneous Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Immune Globulin Subcutaneous

2.9 Immune Globulin Subcutaneous Market Competitive Analysis

2.9.1 Immune Globulin Subcutaneous Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Immune Globulin Subcutaneous Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Globulin Subcutaneous as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 2g

3.1.2 4g

3.1.3 10g

3.1.4 Other

3.2 Global Immune Globulin Subcutaneous Sales Value by Type

3.2.1 Global Immune Globulin Subcutaneous Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Immune Globulin Subcutaneous Sales Value, by Type (2019-2030)

3.2.3 Global Immune Globulin Subcutaneous Sales Value, by Type (%) (2019-2030)

3.3 Global Immune Globulin Subcutaneous Sales Volume by Type

3.3.1 Global Immune Globulin Subcutaneous Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Immune Globulin Subcutaneous Sales Volume, by Type (2019-2030)

3.3.3 Global Immune Globulin Subcutaneous Sales Volume, by Type (%) (2019-2030)

3.4 Global Immune Globulin Subcutaneous Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Immunodeficiency

4.1.2 Autoimmune Disease

4.1.3 Acute Infection

4.2 Global Immune Globulin Subcutaneous Sales Value by Application

4.2.1 Global Immune Globulin Subcutaneous Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Immune Globulin Subcutaneous Sales Value, by Application (2019-2030)

4.2.3 Global Immune Globulin Subcutaneous Sales Value, by Application (%) (2019-2030)

4.3 Global Immune Globulin Subcutaneous Sales Volume by Application

4.3.1 Global Immune Globulin Subcutaneous Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Immune Globulin Subcutaneous Sales Volume, by Application (2019-2030)

4.3.3 Global Immune Globulin Subcutaneous Sales Volume, by Application (%) (2019-2030)

4.4 Global Immune Globulin Subcutaneous Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Immune Globulin Subcutaneous Sales Value by Region

5.1.1 Global Immune Globulin Subcutaneous Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Immune Globulin Subcutaneous Sales Value by Region (2019-2024)

5.1.3 Global Immune Globulin Subcutaneous Sales Value by Region (2025-2030)

5.1.4 Global Immune Globulin Subcutaneous Sales Value by Region (%), (2019-2030)

5.2 Global Immune Globulin Subcutaneous Sales Volume by Region

5.2.1 Global Immune Globulin Subcutaneous Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Immune Globulin Subcutaneous Sales Volume by Region (2019-2024)

5.2.3 Global Immune Globulin Subcutaneous Sales Volume by Region (2025-2030)

5.2.4 Global Immune Globulin Subcutaneous Sales Volume by Region (%), (2019-2030)

5.3 Global Immune Globulin Subcutaneous Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Immune Globulin Subcutaneous Sales Value, 2019-2030

5.4.2 North America Immune Globulin Subcutaneous Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Immune Globulin Subcutaneous Sales Value, 2019-2030

5.5.2 Europe Immune Globulin Subcutaneous Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Immune Globulin Subcutaneous Sales Value, 2019-2030

5.6.2 Asia Pacific Immune Globulin Subcutaneous Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Immune Globulin Subcutaneous Sales Value, 2019-2030

5.7.2 South America Immune Globulin Subcutaneous Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Immune Globulin Subcutaneous Sales Value, 2019-2030

5.8.2 Middle East & Africa Immune Globulin Subcutaneous Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Immune Globulin Subcutaneous Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Immune Globulin Subcutaneous Sales Value

6.2.1 Key Countries/Regions Immune Globulin Subcutaneous Sales Value, 2019-2030

6.2.2 Key Countries/Regions Immune Globulin Subcutaneous Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Immune Globulin Subcutaneous Sales Value, 2019-2030

6.3.2 United States Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Immune Globulin Subcutaneous Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Immune Globulin Subcutaneous Sales Value, 2019-2030

6.4.2 Europe Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Immune Globulin Subcutaneous Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Immune Globulin Subcutaneous Sales Value, 2019-2030

6.5.2 China Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

6.5.3 China Immune Globulin Subcutaneous Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Immune Globulin Subcutaneous Sales Value, 2019-2030

6.6.2 Japan Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Immune Globulin Subcutaneous Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Immune Globulin Subcutaneous Sales Value, 2019-2030

6.7.2 South Korea Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Immune Globulin Subcutaneous Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Immune Globulin Subcutaneous Sales Value, 2019-2030

6.8.2 Southeast Asia Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Immune Globulin Subcutaneous Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Immune Globulin Subcutaneous Sales Value, 2019-2030

6.9.2 India Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

6.9.3 India Immune Globulin Subcutaneous Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Takeda

7.1.1 Takeda Company Information

7.1.2 Takeda Introduction and Business Overview

7.1.3 Takeda Immune Globulin Subcutaneous Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Takeda Immune Globulin Subcutaneous Product Offerings

7.1.5 Takeda Recent Development

7.2 CSL

7.2.1 CSL Company Information

7.2.2 CSL Introduction and Business Overview

7.2.3 CSL Immune Globulin Subcutaneous Sales, Revenue and Gross Margin (2019-2024)

7.2.4 CSL Immune Globulin Subcutaneous Product Offerings

7.2.5 CSL Recent Development

8 Industry Chain Analysis

8.1 Immune Globulin Subcutaneous Industrial Chain

8.2 Immune Globulin Subcutaneous Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Immune Globulin Subcutaneous Sales Model

8.5.2 Sales Channel

8.5.3 Immune Globulin Subcutaneous Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

CSL Limited

Takeda

List of Tables

Table 1. Immune Globulin Subcutaneous Market Trends

Table 2. Immune Globulin Subcutaneous Market Drivers & Opportunity

Table 3. Immune Globulin Subcutaneous Market Challenges

Table 4. Immune Globulin Subcutaneous Market Restraints

Table 5. Global Immune Globulin Subcutaneous Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Immune Globulin Subcutaneous Revenue Market Share by Company (2019-2024)

Table 7. Global Immune Globulin Subcutaneous Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Immune Globulin Subcutaneous Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Immune Globulin Subcutaneous Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Immune Globulin Subcutaneous Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Immune Globulin Subcutaneous Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Immune Globulin Subcutaneous

Table 13. Global Immune Globulin Subcutaneous Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Globulin Subcutaneous as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Immune Globulin Subcutaneous Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Immune Globulin Subcutaneous Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Immune Globulin Subcutaneous Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Immune Globulin Subcutaneous Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Immune Globulin Subcutaneous Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Immune Globulin Subcutaneous Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Immune Globulin Subcutaneous Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Immune Globulin Subcutaneous Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Immune Globulin Subcutaneous Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Immune Globulin Subcutaneous Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Immune Globulin Subcutaneous Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Immune Globulin Subcutaneous Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Immune Globulin Subcutaneous Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Immune Globulin Subcutaneous Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Immune Globulin Subcutaneous Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Immune Globulin Subcutaneous Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Immune Globulin Subcutaneous Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Immune Globulin Subcutaneous Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Immune Globulin Subcutaneous Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Immune Globulin Subcutaneous Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Immune Globulin Subcutaneous Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Immune Globulin Subcutaneous Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Immune Globulin Subcutaneous Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Immune Globulin Subcutaneous Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Immune Globulin Subcutaneous Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Immune Globulin Subcutaneous Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Immune Globulin Subcutaneous Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Immune Globulin Subcutaneous Sales Value by Region (2019-2024) & (%)

Table 44. Global Immune Globulin Subcutaneous Sales Value by Region (2025-2030) & (%)

Table 45. Global Immune Globulin Subcutaneous Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Immune Globulin Subcutaneous Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Immune Globulin Subcutaneous Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Immune Globulin Subcutaneous Sales Volume by Region (2019-2024) & (%)

Table 49. Global Immune Globulin Subcutaneous Sales Volume by Region (2025-2030) & (%)

Table 50. Global Immune Globulin Subcutaneous Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Immune Globulin Subcutaneous Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Immune Globulin Subcutaneous Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Immune Globulin Subcutaneous Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Immune Globulin Subcutaneous Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Immune Globulin Subcutaneous Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Immune Globulin Subcutaneous Sales Volume, (2025-2030) & (K Units)

Table 57. Takeda Company Information

Table 58. Takeda Introduction and Business Overview

Table 59. Takeda Immune Globulin Subcutaneous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Takeda Immune Globulin Subcutaneous Product Offerings

Table 61. Takeda Recent Development

Table 62. CSL Company Information

Table 63. CSL Introduction and Business Overview

Table 64. CSL Immune Globulin Subcutaneous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. CSL Immune Globulin Subcutaneous Product Offerings

Table 66. CSL Recent Development

Table 67. Key Raw Materials Lists

Table 68. Raw Materials Key Suppliers Lists

Table 69. Immune Globulin Subcutaneous Downstream Customers

Table 70. Immune Globulin Subcutaneous Distributors List

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

List of Figures

Figure 1. Immune Globulin Subcutaneous Product Picture

Figure 2. Global Immune Globulin Subcutaneous Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Immune Globulin Subcutaneous Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Immune Globulin Subcutaneous Sales Volume (2019-2030) & (K Units)

Figure 5. Global Immune Globulin Subcutaneous Sales Price (2019-2030) & (USD/Unit)

Figure 6. Immune Globulin Subcutaneous Report Years Considered

Figure 7. Global Immune Globulin Subcutaneous Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Immune Globulin Subcutaneous Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Immune Globulin Subcutaneous Revenue in 2023

Figure 10. Immune Globulin Subcutaneous Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. 2g Picture

Figure 12. 4g Picture

Figure 13. 10g Picture

Figure 14. Other Picture

Figure 15. Global Immune Globulin Subcutaneous Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Immune Globulin Subcutaneous Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Immune Globulin Subcutaneous Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Immune Globulin Subcutaneous Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Immune Globulin Subcutaneous Price by Type (2019-2030) & (USD/Unit)

Figure 20. Product Picture of Immunodeficiency

Figure 21. Product Picture of Autoimmune Disease

Figure 22. Product Picture of Acute Infection

Figure 23. Global Immune Globulin Subcutaneous Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 24. Global Immune Globulin Subcutaneous Sales Value Market Share by Application, 2023 & 2030

Figure 25. Global Immune Globulin Subcutaneous Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 26. Global Immune Globulin Subcutaneous Sales Volume Market Share by Application, 2023 & 2030

Figure 27. Global Immune Globulin Subcutaneous Price by Application (2019-2030) & (USD/Unit)

Figure 28. North America Immune Globulin Subcutaneous Sales Value (2019-2030) & (US$ Million)

Figure 29. North America Immune Globulin Subcutaneous Sales Value by Country (%), 2023 VS 2030

Figure 30. Europe Immune Globulin Subcutaneous Sales Value (2019-2030) & (US$ Million)

Figure 31. Europe Immune Globulin Subcutaneous Sales Value by Country (%), 2023 VS 2030

Figure 32. Asia Pacific Immune Globulin Subcutaneous Sales Value (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Immune Globulin Subcutaneous Sales Value by Country (%), 2023 VS 2030

Figure 34. South America Immune Globulin Subcutaneous Sales Value (2019-2030) & (US$ Million)

Figure 35. South America Immune Globulin Subcutaneous Sales Value by Country (%), 2023 VS 2030

Figure 36. Middle East & Africa Immune Globulin Subcutaneous Sales Value (2019-2030) & (US$ Million)

Figure 37. Middle East & Africa Immune Globulin Subcutaneous Sales Value by Country (%), 2023 VS 2030

Figure 38. Key Countries/Regions Immune Globulin Subcutaneous Sales Value (%), (2019-2030)

Figure 39. Key Countries/Regions Immune Globulin Subcutaneous Sales Volume (%), (2019-2030)

Figure 40. United States Immune Globulin Subcutaneous Sales Value, (2019-2030) & (US$ Million)

Figure 41. United States Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

Figure 42. United States Immune Globulin Subcutaneous Sales Value by Application (%), 2023 VS 2030

Figure 43. Europe Immune Globulin Subcutaneous Sales Value, (2019-2030) & (US$ Million)

Figure 44. Europe Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

Figure 45. Europe Immune Globulin Subcutaneous Sales Value by Application (%), 2023 VS 2030

Figure 46. China Immune Globulin Subcutaneous Sales Value, (2019-2030) & (US$ Million)

Figure 47. China Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

Figure 48. China Immune Globulin Subcutaneous Sales Value by Application (%), 2023 VS 2030

Figure 49. Japan Immune Globulin Subcutaneous Sales Value, (2019-2030) & (US$ Million)

Figure 50. Japan Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

Figure 51. Japan Immune Globulin Subcutaneous Sales Value by Application (%), 2023 VS 2030

Figure 52. South Korea Immune Globulin Subcutaneous Sales Value, (2019-2030) & (US$ Million)

Figure 53. South Korea Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

Figure 54. South Korea Immune Globulin Subcutaneous Sales Value by Application (%), 2023 VS 2030

Figure 55. Southeast Asia Immune Globulin Subcutaneous Sales Value, (2019-2030) & (US$ Million)

Figure 56. Southeast Asia Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

Figure 57. Southeast Asia Immune Globulin Subcutaneous Sales Value by Application (%), 2023 VS 2030

Figure 58. India Immune Globulin Subcutaneous Sales Value, (2019-2030) & (US$ Million)

Figure 59. India Immune Globulin Subcutaneous Sales Value by Type (%), 2023 VS 2030

Figure 60. India Immune Globulin Subcutaneous Sales Value by Application (%), 2023 VS 2030

Figure 61. Immune Globulin Subcutaneous Industrial Chain

Figure 62. Immune Globulin Subcutaneous Manufacturing Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Subcutaneous Injection Immunoglobulin Market Insights Forecast to 2030

Global Subcutaneous Vaccine Adjuvants Market Research Report 2025

Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Immune Globulins Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Subcutaneous Immunotherapy Market Research Report 2024

Subcutaneous Allergy Immunotherapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intravenous Immune Globulin Therapies Market Research Report 2024

Human Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Animal derived Immune Globulin Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Subcutaneous Injection Market Research Report 2024

Global Subcutaneous Medicine Delivery Devices Market Research Report 2024

Global Primary Immunodeficiency Drug Market Research Report 2025

Global Facial Subcutaneous Implants Market Research Report 2024

Primary Immunodeficiency Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sublingual Immunotherapy Market Research Report 2024

Global Subcutaneous Injector Market Research Report 2025

Global Sublingual Allergy Immunotherapy Market Research Report 2024

Global Subcutaneous Biologics Market Research Report 2024

Human Rho D Immune Globulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions